| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.04 | 0.8 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.0065 | 0.8 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |